These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10188953)

  • 1. Antibodies against the beta subunit of voltage-dependent calcium channels in Lambert-Eaton myasthenic syndrome.
    Raymond C; Walker D; Bichet D; Iborra C; Martin-Moutot N; Seagar M; De Waard M
    Neuroscience; 1999 Apr; 90(1):269-77. PubMed ID: 10188953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigens associated with N- and L-type calcium channels in Lambert-Eaton myasthenic syndrome.
    el Far O; Marquèze B; Leveque C; Martin-Moutôt N; Lang B; Newsom-Davis J; Yoshida A; Takahashi M; Seagar MJ
    J Neurochem; 1995 Apr; 64(4):1696-702. PubMed ID: 7891097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
    Martin-Moutot N; de Haro L; Seagar M
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
    Takamori M; Iwasa K; Komai K
    Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome.
    Sher E; Gotti C; Canal N; Scoppetta C; Piccolo G; Evoli A; Clementi F
    Lancet; 1989 Sep; 2(8664):640-3. PubMed ID: 2570899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant calcium channel is recognized by Lambert-Eaton myasthenic syndrome antibodies.
    Iwasa K; Takamori M; Komai K; Mori Y
    Neurology; 2000 Feb; 54(3):757-9. PubMed ID: 10680821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.
    Hajela RK; Huntoon KM; Atchison WD
    Muscle Nerve; 2015 Feb; 51(2):176-84. PubMed ID: 24862203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum.
    Arsac C; Raymond C; Martin-Moutot N; Dargent B; Couraud F; Pouget J; Seagar M
    Ann Neurol; 1996 Nov; 40(5):695-700. PubMed ID: 8957009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
    Flink MT; Atchison WD
    J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Leys K; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Mar; 29(3):307-14. PubMed ID: 1645944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts].
    Eymard B
    Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.
    Verschuuren JJ; Dalmau J; Tunkel R; Lang B; Graus F; Schramm L; Posner JB; Newsom-Davis J; Rosenfeld MR
    Neurology; 1998 Feb; 50(2):475-9. PubMed ID: 9484375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
    Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
    Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.
    Leveque C; Hoshino T; David P; Shoji-Kasai Y; Leys K; Omori A; Lang B; el Far O; Sato K; Martin-Moutot N
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3625-9. PubMed ID: 1314395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.